Sepsis occurs when chemicals released in the bloodstream to fight an infection trigger inflammation throughout the body. This can cause a cascade of changes that damage multiple organ systems, leading them to fail, sometimes even resulting in death. Sepsis symptoms include fever, difficulty breathing, low blood pressure, fast heart rate and mental confusion. Sepsis treatment includes antibiotics and intravenous fluids.
Currently, there are more than 40 drugs in the Sepsis pipeline, which are under different phases of development.
DelveInsight brings into attention the current Sepsis market trends, epidemiology, diagnosis, and treatment prospects with our clients and readers through this newsletter. Learn more about the recent happenings, ongoing research & development, significant pharmaceutical companies involved in the Sepsis market, top-notch collaborations anticipated to occur, licensing & fundings, and major breakthroughs in the Sepsis market landscape.
Get a sneak-peak at the Sepsis pipeline therapies, clinical trials, deals & tie-ups, upcoming world-class conferences, as well as track all the recent updates in the Sepsis market. Find the newsletter directly mailed to your email box by filling up a simple form towards your right. Join our Newsletter series and get rich insights delivered every week to you.
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Epidemiological trends
- Treatment approaches
- R&D in the field
- Top conferences
- News Flash
- Recent Research Activities
- Support from International organizations
- Market insights
- Market Dynamics
- Collaborations and deals in the domain